Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine adjunct to propofol and sufentanil for cervical conization anesthesia
ChiCTR2000040457Phase 4Not yet recruiting
- Sponsor
- Zibo City Central Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in cervical intraepithelial neoplasia (CIN) (2 arms), sponsored by Zibo City Central Hospital. Primary endpoint: Respiratory related adverse sedation event. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on ChiCTR2000040457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040457.